At Stock Options Channel, our YieldBoost formula has looked up and down the JNJ options chain for the new May 30th contracts and identified one put and one call contract of particular interest.

Regeneron Pharmaceuticals said on Tuesday it had entered into a deal valued at more than $3 billion with contract drug ...

Johnson & Johnson (NYSE:JNJ) said that its acquisition of Intra-Cellular Therapies (NASDAQ:ITCI) is expected to be completed on or around April 2, 2025, pending approvals. The company corrected an ...

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S.

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Multi-Factor Investor model based on the published strategy ...

One of the best pharma stocks to add to your portfolio is Johnson & Johnson (JNJ), a blue chip healthcare company with a long history of rewarding shareholders. It boasts a strong balance sheet ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

Johnson & Johnson is scheduled to announce its earnings on Tuesday, April 15, 2025. Analysts expect earnings of $2.59 per share on revenue of $21.6 billion for the current year, compared to $2.71 ...

Johnson & Johnson (NYSE:JNJ) announced on Saturday the initial results from a group of patients who were part of its SunRISe-1 Phase 2b trial for TAR-200, an intravesical releasing system of ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other value stocks in Ken Fisher’s portfolio. Trump’s “stupid” tariffs will fail ...